Taysha Gene Therapies, Inc. (TSHA) Earnings
NASDAQ·Healthcare·Biotechnology
$5.02
-2.81%
Mkt Cap $1.79B
EPS — Estimate vs Actual
Mkt Cap
$1.79B
P/E
—
Fwd P/E
—
P/S
239.76
Rev TTM
—
EPS TTM
-$0.38
NASDAQ·Healthcare·Biotechnology
$5.02
-2.81%
Mkt Cap $1.79B
Mkt Cap
$1.79B
P/E
—
Fwd P/E
—
P/S
239.76
Rev TTM
—
EPS TTM
-$0.38